WEBINAR 1: SAFE Disease Model—IBD Model

Aug.16 2023

Inflammatory Bowel Disease (IBD) describes conditions characterized by chronic inflammation of the gastrointestinal tract. The two most common inflammatory bowel diseases are Crohn’s disease and ulcerative colitis.The exact cause of IBD is unknown, but IBD is the result of a weakened immune system. Possible causes are: 1. The immune system responds incorrectly to environmental triggers, such as a virus or bacteria, which causes inflammation of the gastrointestinal tract. 2. There also appears to be a genetic component. Someone with a family history of IBD is more likely to develop this inappropriate immune response.

Dr. Tian explains us with the different 5 types of models which are popular in IBD research and their applications. SAFE has rich experience on IBD model establishment and application, SAFE has done more 20 IBD cases. Welcome to contact us to know more about animal models.


Dr. Jun Tian 

Sub-Manager of Pharmacology and Pharmacodynamics Center 

SAFE Pharmaceutical Techonology Co., Ltd.

Dr. Tian got his Ph. D degree in Immunology and M.S. in Biochemistry. He is an Associate Professor of Immunology at the Institute of Cardiopulmonary and Vascular Research in Beijing. 

He has been working as a researcher at the Institute of Basic Medical Sciences, and worked as a laboratory manager in the U.S. for several years. Dr. Jun Tian is familiar with cutting-edge research in immunology, oncology immune drugs and therapeutics, and the evaluation of the pharmacology and pharmacological efficacy of animal and humanized models.

Next webinar will be coming soon....